Was the Myomo (MYO) insider share disposition an open-market sale?

The filing explains the 10,442 shares were sold solely to pay income taxes from a June 11, 2026 restricted stock unit vesting. It describes a tax-withholding disposition under an irrevocable election, rather than a discretionary open‑market trading decision.

What price per share was reported in the Myomo (MYO) Form 4 transaction?

The Form 4 lists a transaction price of $1.20 per share for the 10,442 Myomo Common Stock shares sold on June 12, 2026. This price is associated with the tax-related disposition linked to restricted stock unit vesting.

Myomo CMO disposes shares for tax withholding

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

MYOMO, INC. Chief Medical Officer Harry Kovelman reported a Form 4 transaction where 10,442 shares of Common Stock were sold at $1.20 per share on June 12, 2026. According to the footnote, these shares were sold solely to pay income taxes from restricted stock units that vested on June 11, 2026, under an earlier irrevocable election. After this tax-withholding disposition, Kovelman directly owns 90,541 shares.

Insider Trade Summary

Exercise Price or Tax Liability: 10,442 shares

Exercise Price or Tax Liability 1 txn

Insider Kovelman Harry

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	10,442	$1.20	$13K

Holdings After Transaction: Common Stock — 90,541 shares (Direct)

Footnotes (1)

F1. Represents shares sold on June 12, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 11, 2026, purusant to an irrevocable election made by the Reporting Party on May 28, 2026.

Key Figures

Shares disposed for taxes: 10,442 shares Transaction price per share: $1.20 per share Shares held after transaction: 90,541 shares +1 more

4 metrics

Shares disposed for taxes 10,442 shares Tax-withholding sale on June 12, 2026

Transaction price per share $1.20 per share Common Stock disposition on June 12, 2026

Shares held after transaction 90,541 shares Direct ownership following June 12, 2026 Form 4

Tax-withholding transactions in filing 1 transaction Form 4 transaction summary

Key Terms

restricted stock units, tax-withholding disposition, irrevocable election

3 terms

restricted stock units financial

"resulting from a vesting of restrcted stock units on June 11, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" for this sale"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

irrevocable election financial

"pursuant to an irrevocable election made by the Reporting Party on May 28, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Myomo (MYO) disclose in Harry Kovelman’s latest Form 4?

Myomo reported that Chief Medical Officer Harry Kovelman disposed of 10,442 shares of Common Stock on June 12, 2026. The filing states the transaction was specifically to cover income taxes from recently vested restricted stock units.

How many Myomo (MYO) shares does Harry Kovelman hold after this Form 4?

After the June 12, 2026 tax-withholding disposition, Chief Medical Officer Harry Kovelman directly holds 90,541 shares of Myomo Common Stock. This figure reflects his position immediately following the reported transaction in the Form 4 filing.

Does the Myomo (MYO) Form 4 show insider buying or selling activity?

The Form 4 reflects a disposition of 10,442 shares categorized as a tax-withholding transaction, not an open-market purchase. Shares were sold solely to satisfy income taxes from restricted stock unit vesting, rather than to change investment exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/12/2026 - 05:06 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kovelman Harry

(Last)

(First)

(Middle)

C/O MYOMO, INC.

45 BLUE SKY DR., SUITE 101

(Street)

BURLINGTON

MASSACHUSETTS

01803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/12/2026		F		10,442⁽¹⁾	D	$1.2	90,541	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares sold on June 12, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 11, 2026, purusant to an irrevocable election made by the Reporting Party on May 28, 2026.

	/s/ David A. Henry, Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR